Cellular therapy

FDA Approves Talquetamab-Tgvs For Adults with Relapsed Or Refractory Multiple Myeloma Patients with at least Four Prior Lines of Therapy

By Dr. Anish Shah Bronx Lebanon Hospital   On August 9, 2023, the U.S. Food and Drug Administration approved talquetamab-tgvs…

1 year ago

Binaytara Foundation Hosted Seattle Cellular Therapy Summit

Hematologists & Oncologists from Across Country Met to Discuss Latest Updates in Care   On August 4-5, 2023, the Binaytara…

1 year ago

Binaytara Foundation September Conferences

The Binaytara Foundation hosted two conferences in September 2022

2 years ago